Titre : Nigella

Nigella : Questions médicales fréquentes

Nom anglais: Nigella

Descriptor UI: D031844

Tree Number: B01.875.800.575.912.250.836.750.518

Termes MeSH sélectionnés :

Osteosarcoma

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment diagnostiquer une allergie à Nigella ?

Un test cutané ou un test sanguin peut confirmer une allergie aux composants de Nigella.
Allergies Tests cutanés
#2

Quels tests pour évaluer l'efficacité de Nigella ?

Des études cliniques et des essais contrôlés randomisés sont nécessaires pour évaluer son efficacité.
Essais cliniques Efficacité thérapeutique

Symptômes 2

#1

Quels sont les symptômes d'une intoxication à Nigella ?

Les symptômes incluent des nausées, vomissements, et des douleurs abdominales.
Intoxication alimentaire Symptômes
#2

Nigella peut-elle provoquer des effets secondaires ?

Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir.
Effets indésirables Troubles gastro-intestinaux

Prévention 2

#1

Nigella peut-elle prévenir certaines maladies ?

Oui, elle est étudiée pour ses effets préventifs sur les maladies cardiovasculaires.
Prévention des maladies Maladies cardiovasculaires
#2

Comment intégrer Nigella dans l'alimentation ?

On peut ajouter les graines de Nigella dans les plats, salades ou infusions.
Nutrition Alimentation

Traitements 2

#1

Comment utiliser Nigella pour l'inflammation ?

L'huile de Nigella peut être appliquée localement ou ingérée pour réduire l'inflammation.
Anti-inflammatoires Huile essentielle
#2

Nigella est-elle efficace contre le diabète ?

Des études montrent que Nigella peut aider à réguler la glycémie chez les diabétiques.
Diabète Glycémie

Complications 2

#1

Quelles complications peuvent survenir avec Nigella ?

Des complications comme des réactions allergiques sévères peuvent survenir chez certains individus.
Réactions allergiques Complications
#2

Nigella peut-elle interagir avec des médicaments ?

Oui, elle peut interagir avec des anticoagulants et d'autres médicaments, nécessitant prudence.
Interactions médicamenteuses Anticoagulants

Facteurs de risque 2

#1

Qui devrait éviter Nigella ?

Les personnes allergiques aux plantes de la famille des renonculacées doivent l'éviter.
Allergies Renonculacées
#2

Quels sont les risques d'une surconsommation de Nigella ?

Une surconsommation peut entraîner des troubles digestifs et des effets indésirables.
Surconsommation Troubles digestifs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nigella : Questions médicales les plus fréquentes", "headline": "Nigella : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nigella : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-18", "dateModified": "2025-04-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nigella" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Ranonculaceae", "url": "https://questionsmedicales.fr/mesh/D029626", "about": { "@type": "MedicalCondition", "name": "Ranonculaceae", "code": { "@type": "MedicalCode", "code": "D029626", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Nigella damascena", "alternateName": "Nigella damascena", "url": "https://questionsmedicales.fr/mesh/D031861", "about": { "@type": "MedicalCondition", "name": "Nigella damascena", "code": { "@type": "MedicalCode", "code": "D031861", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750.518.500" } } }, { "@type": "MedicalWebPage", "name": "Nigella sativa", "alternateName": "Nigella sativa", "url": "https://questionsmedicales.fr/mesh/D031881", "about": { "@type": "MedicalCondition", "name": "Nigella sativa", "code": { "@type": "MedicalCode", "code": "D031881", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750.518.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Nigella", "alternateName": "Nigella", "code": { "@type": "MedicalCode", "code": "D031844", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xu Yao", "url": "https://questionsmedicales.fr/author/Xu%20Yao", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Hongyan Shan", "url": "https://questionsmedicales.fr/author/Hongyan%20Shan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Hongzhi Kong", "url": "https://questionsmedicales.fr/author/Hongzhi%20Kong", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Erdem Yeşilada", "url": "https://questionsmedicales.fr/author/Erdem%20Ye%C5%9Filada", "affiliation": { "@type": "Organization", "name": "Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, 34755, Istanbul, Turkey." } }, { "@type": "Person", "name": "Xiaoshan Duan", "url": "https://questionsmedicales.fr/author/Xiaoshan%20Duan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Osteosarcoma.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36481668", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41572-022-00409-y" } }, { "@type": "ScholarlyArticle", "name": "Advances in Osteosarcoma.", "datePublished": "2023-06-17", "url": "https://questionsmedicales.fr/article/37329384", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11914-023-00803-9" } }, { "@type": "ScholarlyArticle", "name": "Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group.", "datePublished": "2023-03-17", "url": "https://questionsmedicales.fr/article/36928868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cncr.34744" } }, { "@type": "ScholarlyArticle", "name": "Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group.", "datePublished": "2023-02-25", "url": "https://questionsmedicales.fr/article/36842425", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jgo.2023.101445" } }, { "@type": "ScholarlyArticle", "name": "Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36311748", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.871076" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Viridiplantae", "item": "https://questionsmedicales.fr/mesh/D057948" }, { "@type": "ListItem", "position": 4, "name": "Streptophyta", "item": "https://questionsmedicales.fr/mesh/D057949" }, { "@type": "ListItem", "position": 5, "name": "Embryophyta", "item": "https://questionsmedicales.fr/mesh/D019669" }, { "@type": "ListItem", "position": 6, "name": "Tracheobionta", "item": "https://questionsmedicales.fr/mesh/D064028" }, { "@type": "ListItem", "position": 7, "name": "Magnoliopsida", "item": "https://questionsmedicales.fr/mesh/D019684" }, { "@type": "ListItem", "position": 8, "name": "Ranunculales", "item": "https://questionsmedicales.fr/mesh/D000076664" }, { "@type": "ListItem", "position": 9, "name": "Ranonculaceae", "item": "https://questionsmedicales.fr/mesh/D029626" }, { "@type": "ListItem", "position": 10, "name": "Nigella", "item": "https://questionsmedicales.fr/mesh/D031844" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nigella - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nigella", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Nigella", "description": "Comment diagnostiquer une allergie à Nigella ?\nQuels tests pour évaluer l'efficacité de Nigella ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Osteosarcoma#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Nigella", "description": "Quels sont les symptômes d'une intoxication à Nigella ?\nNigella peut-elle provoquer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Osteosarcoma#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Nigella", "description": "Nigella peut-elle prévenir certaines maladies ?\nComment intégrer Nigella dans l'alimentation ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Osteosarcoma#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Nigella", "description": "Comment utiliser Nigella pour l'inflammation ?\nNigella est-elle efficace contre le diabète ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Osteosarcoma#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Nigella", "description": "Quelles complications peuvent survenir avec Nigella ?\nNigella peut-elle interagir avec des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Osteosarcoma#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Nigella", "description": "Qui devrait éviter Nigella ?\nQuels sont les risques d'une surconsommation de Nigella ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Osteosarcoma#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une allergie à Nigella ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané ou un test sanguin peut confirmer une allergie aux composants de Nigella." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'efficacité de Nigella ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des études cliniques et des essais contrôlés randomisés sont nécessaires pour évaluer son efficacité." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication à Nigella ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, vomissements, et des douleurs abdominales." } }, { "@type": "Question", "name": "Nigella peut-elle provoquer des effets secondaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir." } }, { "@type": "Question", "name": "Nigella peut-elle prévenir certaines maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est étudiée pour ses effets préventifs sur les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment intégrer Nigella dans l'alimentation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "On peut ajouter les graines de Nigella dans les plats, salades ou infusions." } }, { "@type": "Question", "name": "Comment utiliser Nigella pour l'inflammation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'huile de Nigella peut être appliquée localement ou ingérée pour réduire l'inflammation." } }, { "@type": "Question", "name": "Nigella est-elle efficace contre le diabète ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent que Nigella peut aider à réguler la glycémie chez les diabétiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Nigella ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des réactions allergiques sévères peuvent survenir chez certains individus." } }, { "@type": "Question", "name": "Nigella peut-elle interagir avec des médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut interagir avec des anticoagulants et d'autres médicaments, nécessitant prudence." } }, { "@type": "Question", "name": "Qui devrait éviter Nigella ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux plantes de la famille des renonculacées doivent l'éviter." } }, { "@type": "Question", "name": "Quels sont les risques d'une surconsommation de Nigella ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles digestifs et des effets indésirables." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale

Validation scientifique effectuée le 14/04/2025

Contenu vérifié selon les dernières recommandations médicales

En savoir plus sur Dr Menir

Sous-catégories

2 au total
└─

Nigella damascena

Nigella damascena D031861 - B01.875.800.575.912.250.836.750.518.500
└─

Nigella sativa

Nigella sativa D031881 - B01.875.800.575.912.250.836.750.518.750

Auteurs principaux

Xu Yao

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
Publications dans "Nigella" :

Hongyan Shan

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
Publications dans "Nigella" :

Hongzhi Kong

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
Publications dans "Nigella" :

Erdem Yeşilada

3 publications dans cette catégorie

Affiliations :
  • Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, 34755, Istanbul, Turkey.
Publications dans "Nigella" :

Xiaoshan Duan

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
Publications dans "Nigella" :

Rui Zhang

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
Publications dans "Nigella" :

Xuehao Fu

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, 100093, Beijing, China.
  • University of Chinese Academy of Sciences, 100049, Beijing, China.
Publications dans "Nigella" :

Jie Cheng

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, 100093, Beijing, China.
  • University of Chinese Academy of Sciences, 100049, Beijing, China.
Publications dans "Nigella" :

Naina Mohamed Pakkir Maideen

3 publications dans cette catégorie

Affiliations :
  • Dubai Health Authority Clinical Pharmacy Dubai United Arab Emirates.
Publications dans "Nigella" :

Sharf Ilahi Siddiqui

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Jamia Millia Islamia, New Delhi 110025, India.
Publications dans "Nigella" :

Saif Ali Chaudhry

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Jamia Millia Islamia, New Delhi 110025, India. Electronic address: schaudhry@jmi.ac.in.
Publications dans "Nigella" :

Yi Yuan

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
Publications dans "Nigella" :

Raluca Maria Pop

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
Publications dans "Nigella" :

Veronica Sanda Chedea

2 publications dans cette catégorie

Affiliations :
  • Research Station for Viticulture and Enology, 515400 Blaj, Romania.
Publications dans "Nigella" :

Ioana Corina Bocsan

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
Publications dans "Nigella" :

Anca Dana Buzoianu

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
Publications dans "Nigella" :

Mohammad Reza Khazdair

2 publications dans cette catégorie

Affiliations :
  • Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Publications dans "Nigella" :

Mohammad Hossein Boskabady

2 publications dans cette catégorie

Affiliations :
  • Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: boskabadymh@mums.ac.ir.
Publications dans "Nigella" :

Klaudia Ciesielska-Figlon

2 publications dans cette catégorie

Affiliations :
  • Department of Pathophysiology, Faculty of Medicine, Medical University of Gdansk, Poland.
Publications dans "Nigella" :

Katarzyna A Lisowska

2 publications dans cette catégorie

Affiliations :
  • Department of Pathophysiology, Faculty of Medicine, Medical University of Gdansk, Poland. Electronic address: katarzyna.lisowska@gumed.edu.pl.
Publications dans "Nigella" :

Sources (1994 au total)

Advances in Osteosarcoma.

08 2023
DOI: 10.1007/s11914-023-00803-9 PMID: 37329384

This article gives a brief overview of the most recent developments in osteosarcoma treatment, including targeting of signaling pathways, immune checkpoint inhibitors, drug delivery strategies as sing... Osteosarcoma is one of the most common primary malignant bone tumors in children and young adults, with a high risk of bone and lung metastases and a 5-year survival rate around 70% in the absence of ...

Child Young Adult Humans Immune Checkpoint Inhibitors Osteosarcoma +4 autres

Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group.

15 06 2023
DOI: 10.1002/cncr.34744 PMID: 36928868

Primary rib osteosarcoma has not been investigated extensively, and clinical characteristics and optimal therapeutic strategies have not been defined. The authors used the database of the Cooperative ... The COSS database was searched for treatment-naive, high-grade osteosarcomas of the rib. Affected patients were analyzed for demographic and tumor-related factors, treatments, and outcomes.... A total of 44 patients (23 males, 21 females; median age, 23 years [range, 6-59]) were identified. Primary metastases were detected in six of 44 (14%) patients. Surgery was performed in 40 of 44 (91%)... This large series provides evidence that patients with costal primaries are older than the average osteosarcoma patient, but appear to share the similar tumor biology and-if treated according to stand...

Male Female Humans Young Adult Adult +6 autres

Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group.

04 2023
DOI: 10.1016/j.jgo.2023.101445 PMID: 36842425

Osteosarcoma is typically a disease of the young, but may affect any age. Little is known about the disease in older patients beyond retirement age. We aim to describe the characteristics, treatment, ... The database of the Cooperative Osteosarcoma Study Group (COSS) was searched for osteosarcoma patients diagnosed from 1980 to 2020 who were aged 65 years or older at diagnosis. Affected individuals we... Fifty-five eligible patients were detected (median age 68 [range: 65-84] years; male:female = 25:30). Among these patients, 15/55 (27%) tumors were secondary malignancies, 41/55 (75%) were high-grade ... Osteosarcomas can occur in older individuals. It is more often secondary, axially located, or extraosseous than in younger patients. However, the same treatment principles seem to apply, and selected ...

Humans Male Female Aged Osteosarcoma +2 autres

Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.

Sep 2022
DOI: 10.1111/his.14721 PMID: 35791778

Chondroblastoma-like osteosarcoma (CBLOS) is a rare and poorly understood variant of OS. We examined the clinicopathological, immunohistochemical and molecular features of six CBLOSs to highlight the ... We performed histone 3.3 mutation analysis by gene sequencing and/or immunohistochemistry in all cases, while whole exome sequencing (WES) was performed on two CB-like osteosarcomas and 11 conventiona... CBLOSs were predominantly localised at acral sites and involved mainly male subjects with a mean age of 29 years. One patient who had metastases at presentation died of disease, while another patient ... CBLOS presents a different genetic background and a less aggressive clinical behaviour in comparison with CHGOS. Search of the H3F3B K36M mutation is useful in the differential diagnosis with CB....

Adult Antibodies Bone Neoplasms Chondroblastoma Female +5 autres

FKBP11 improves the malignant property of osteosarcoma cells and acts as a prognostic factor of osteosarcoma.

01 04 2023
DOI: 10.18632/aging.204523 PMID: 37014329

Osteosarcoma has become the most common bone malignancy in adolescents. Although the clinical treatment of osteosarcoma has advanced considerably in recent years, the 5-year survival rate has not impr... We selected prognostic genes that are closely associated with osteosarcoma clinical features by obtaining osteosarcoma patient information from the GTEx and TARGET databases, and then we developed a r... In conclusion, we validated that the prognostic factor FKBP11 is closely associated with osteosarcoma. Additionally, we identified a novel mechanism by which FKBP11 ameliorates the malignant propertie...

Humans Adolescent Prognosis Osteosarcoma Cell Proliferation +6 autres

Management of osteosarcoma of the head and neck.

01 Aug 2023
DOI: 10.1097/MOO.0000000000000900 PMID: 37144500

There is no clear consensus guideline that specifies the optimum course of treatment for adult head and neck osteosarcoma (HNO) because of its rarity. The review's goal is to examine the most recent r... Due to overlapping symptoms with various benign disorders of the lower jaw and midface bone, these patients present with a noticeable delay. The greatest results for these malignancies can be achieved... Multimodality treatments seem to yield better results for advanced HNO with adverse features and incomplete resections....

Adult Humans Osteosarcoma Combined Modality Therapy Prognosis +2 autres